ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ABOS Acumen Pharmaceuticals Inc

3.595
0.115 (3.30%)
Última actualización: 09:01:02
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Acumen Pharmaceuticals Inc ABOS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.115 3.30% 3.595 09:01:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.58 3.55 3.64 3.48
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202407:00GLOBEAcumen Pharmaceuticals Presents First Comprehensive Clinical..
04/4/202407:00GLOBEAcumen Pharmaceuticals Collaborates with Lonza to Advance..
26/3/202406:00GLOBEAcumen Pharmaceuticals Reports Financial Results for the..
21/3/202407:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights, Including..
19/3/202415:00GLOBEAcumen Pharmaceuticals to Report Fourth Quarter and Year-End..
12/3/202415:00GLOBEAcumen Pharmaceuticals to Participate in the Stifel 2024 CNS..
08/3/202407:50GLOBEAcumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid..
21/2/202407:00GLOBEAcumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid..
14/2/202407:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202416:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/2/202406:16EDGAR2Form 8-K - Current report
01/2/202406:00GLOBEAcumen Pharmaceuticals Appoints Dr. James Doherty as..
19/1/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202418:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:36EDGAR2Form 144 - Report of proposed sale of securities
19/1/202415:35EDGAR2Form 144 - Report of proposed sale of securities
18/1/202415:29EDGAR2Form 144 - Report of proposed sale of securities
18/1/202415:28EDGAR2Form 144 - Report of proposed sale of securities
18/1/202415:27EDGAR2Form 144 - Report of proposed sale of securities
12/1/202407:42EDGAR2Form 8-K - Current report
08/1/202407:33EDGAR2Form 8-K - Current report
04/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:15GLOBEAcumen Pharmaceuticals to Present at the 42nd Annual J.P...
04/12/202306:45EDGAR2Form 8-K - Current report
13/11/202316:10EDGAR2Form 8-K - Current report
13/11/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:20EDGAR2Form 8-K - Current report
13/11/202306:00GLOBEAcumen Pharmaceuticals Reports Third Quarter 2023 Financial..
07/11/202315:01GLOBEAcumen Pharmaceuticals to Participate in the Stifel..
06/11/202315:01GLOBEAcumen Pharmaceuticals to Report Third Quarter Financial..
06/11/202306:30GLOBEAcumen Pharmaceuticals, Inc. and Halozyme Enter Global..
02/11/202315:00GLOBEAcumen Pharmaceuticals to Participate in the UBS Biopharma..
27/10/202308:25GLOBEAcumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates..
04/10/202307:00GLOBEAcumen Pharmaceuticals to Present Deeper Insights from..
19/9/202315:00GLOBEAcumen Pharmaceuticals to Participate in the Cantor Global..
06/9/202315:00GLOBEAcumen Pharmaceuticals to Participate in the H.C. Wainwright..
18/8/202317:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202310:46EDGAR2Form 144 - Report of proposed sale of securities
08/8/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:33EDGAR2Form 8-K - Current report
08/8/202306:00GLOBEAcumen Pharmaceuticals Reports Second Quarter 2023 Financial..
01/8/202315:00GLOBEAcumen Pharmaceuticals to Report Second Quarter Financial..

Su Consulta Reciente

Delayed Upgrade Clock